Concepedia

Karen Fang

KF

2

Publications

90

Citations

2

H-Index

2009

Active since

Affiliations

Toronto General Hospital Research Institute(Current)

Karen Fang is an author at Toronto General Hospital Research Institute.

Publications per year

2009–2023

2

Publications

2

QLT0267, a small molecule inhibitor targeting integrin-linked kinase (ILK), and docetaxel can combine to produce synergistic interactions linked to enhanced cytotoxicity, reductions in P-AKT levels, altered F-actin architecture and improved treatment outcomes in an orthotopic breast cancer model

Jessica Kalra, Corinna Warburton, Karen Fang et al. · Breast Cancer Research · 2009 · 73 citations · Full text

Targeting T-cell malignancies using allogeneic double-negative CD4-CAR-T cells

Karen Fang, Jongbok Lee, Ismat Khatri et al. · Journal for ImmunoTherapy of Cancer · 2023 · 17 citations · Full text

Rows per page

1–2 of 2